Crescita Therapeutics Inc T.CTX

Alternate Symbol(s): CRRTF

Healthcare

Crescita Therapeutics Inc. is a commercial dermatology company with in-house research and development (R&D) and manufacturing capabilities. It offers a portfolio of science-based non-prescription skincare products and early to commercial stage prescription products. It operates in three segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. The Commercial Skincare segment manufactures and sells branded non-prescription skincare products for the Canadian and international markets. It also commercializes Pliaglis, NCTF Boost 135 HA, ART FILLER, and Obagi Medical in Canada. The Licensing and Royalties segment engaged in licensing the intellectual property related to Pliaglis or its transdermal delivery technologies. Manufacturing and Services segment engaged in the sale of topical products manufactured to client specifications under the Company’s contract development and manufacturing organization infrastructure, and product development services.

TSX:CTX - Post by User

Crescita Therapeutics Inc

<< Previous

Bullboard Posts

Next >>

Post by lscfaon Mar 15, 2024 12:37am

227 Views

Post# 35934218

Q4 on sedar

Skincare biz growing. Looking for new customers for their contract manufacturing biz where the plant has a capacity of $25 mil/yr.

	Skincare	Licensing	Manufacturing	Total rev	ebitda
Dec 23	2,851	1,547	327	4,725	245
Sep 23	2,412	163	458	3,033	(988)
Jun 23	2,685	299	2,178	5,162	214
Mar 23	2,492	21	2,089	4,602	161
Dec 22	2,422	1,481	2,127	6,030	997
Sep 22	1,672	92	4,268	6,032	512
Jun 22	2,392	227	3,893	6,512	646
Mar 22	1,536	0	3,415	4,951	66